BTIG: 'we think BSX remains a name to own'
Tweet Send to a Friend
BTIG analyst Marie Thibault reiterated a Buy rating and $132.00 price target on Boston Scientific (NYSE: BSX).The analyst comments "Boston ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


